Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie Bertrand

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
British Journal of Clinical Pharmacology|February 16, 2023
A population pharmacokinetic model to guide clozapine dose selection, based on age, sex, ethnicity, body weight and smoking statusSuzanne Reeves, Julie Bertrand, Stephen John Obee, et al.
JCO Precision Oncology|February 27, 2023
Assessing the Increased Variability in Individual Lesion Kinetics During Immunotherapy: Does It Exist, and Does It Matter?Marion Kerioui, Julie Bertrand, Solène Desmée, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 20, 2019
Misidentification Subtype of Alzheimer's Disease Psychosis Predicts a Faster Cognitive DeclineFabrizia D'Antonio, Suzanne Reeves, Yucheng Sheng, et al.
Biometrics|July 27, 2023
Nonlinear multilevel joint model for individual lesion kinetics and survival to characterize intra-individual heterogeneity in patients with advanced cancerMarion Kerioui, Maxime Beaulieu, Solène Desmée, et al.
Elife|September 27, 2021
Quantifying the relationship between SARS-CoV-2 viral load and infectiousnessAurélien Marc, Marion Kerioui, François Blanquart, et al.
Clinical Pharmacology and Therapeutics|August 23, 2025
Levofloxacin in Bone and Joint Infections: Development of an Application for Model-Informed Precision DosingLéo Mimram, Sophie Magreault, Florian Lemaitre, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 28, 2024
Isatuximab-dexamethasone-pomalidomide combination effects on serum M protein and PFS in myeloma: Development of a joint model using phase I/II dataAntoine Pitoy, Solène Desmée, François Riglet, et al.
Drugs in R&D|October 7, 2020
Population Pharmacokinetic Model of Plasma and Cellular Mycophenolic Acid in Kidney Transplant Patients from the CIMTRE StudyFrançois Riglet, Julie Bertrand, Aurélie Barrail-Tran, et al.
Antimicrobial Agents and Chemotherapy|September 27, 2017
Genetics of Nevirapine Metabolic Pathways at Steady State in HIV-Infected CambodiansPhilippine Eloy, Adrien Tessier, Patty Fan-Havard, et al.
Pharmacogenetics and Genomics|October 30, 2012
Multiple genetic variants predict steady-state nevirapine clearance in HIV-infected CambodiansJulie Bertrand, Monidarin Chou, Danielle M Richardson, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
British Journal of Clinical Pharmacology|February 16, 2023
A population pharmacokinetic model to guide clozapine dose selection, based on age, sex, ethnicity, body weight and smoking statusSuzanne Reeves, Julie Bertrand, Stephen John Obee, et al.
JCO Precision Oncology|February 27, 2023
Assessing the Increased Variability in Individual Lesion Kinetics During Immunotherapy: Does It Exist, and Does It Matter?Marion Kerioui, Julie Bertrand, Solène Desmée, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 20, 2019
Misidentification Subtype of Alzheimer's Disease Psychosis Predicts a Faster Cognitive DeclineFabrizia D'Antonio, Suzanne Reeves, Yucheng Sheng, et al.
Biometrics|July 27, 2023
Nonlinear multilevel joint model for individual lesion kinetics and survival to characterize intra-individual heterogeneity in patients with advanced cancerMarion Kerioui, Maxime Beaulieu, Solène Desmée, et al.
Elife|September 27, 2021
Quantifying the relationship between SARS-CoV-2 viral load and infectiousnessAurélien Marc, Marion Kerioui, François Blanquart, et al.
Clinical Pharmacology and Therapeutics|August 23, 2025
Levofloxacin in Bone and Joint Infections: Development of an Application for Model-Informed Precision DosingLéo Mimram, Sophie Magreault, Florian Lemaitre, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 28, 2024
Isatuximab-dexamethasone-pomalidomide combination effects on serum M protein and PFS in myeloma: Development of a joint model using phase I/II dataAntoine Pitoy, Solène Desmée, François Riglet, et al.
Drugs in R&D|October 7, 2020
Population Pharmacokinetic Model of Plasma and Cellular Mycophenolic Acid in Kidney Transplant Patients from the CIMTRE StudyFrançois Riglet, Julie Bertrand, Aurélie Barrail-Tran, et al.
Antimicrobial Agents and Chemotherapy|September 27, 2017
Genetics of Nevirapine Metabolic Pathways at Steady State in HIV-Infected CambodiansPhilippine Eloy, Adrien Tessier, Patty Fan-Havard, et al.
Pharmacogenetics and Genomics|October 30, 2012
Multiple genetic variants predict steady-state nevirapine clearance in HIV-infected CambodiansJulie Bertrand, Monidarin Chou, Danielle M Richardson, et al.
Pageof 6